Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 8, Issue 7 July 2012
SPECIAL FOCUS COMMENTARIES
Report from the field: Fifth vaccine renaissance in Providence RI
Denice Spero, Nikolai Petrovsky and Annie De Groo
Emerging and re-emerging infectious diseases represent a major challenge to vaccine development since it involves two seemingly contradictory requirements. Rapid and flexible vaccine generation while using technologies and processes that can facilitate accelerated regulatory review. Development in the “-omics” in combination with advances in vaccinology offer novel opportunities to meet these requirements. Here we describe how a consortium of five different organizations from academia and industry is addressing these challenges. This novel approach has the potential to become the new standard in vaccine development allowing timely deployment to avert potential pandemics.